Bayer Schering Pharma AG et al v. Lupin Ltd et al

Filing 91

ORDER granting Defendants Lupin Limited's and Lupin Pharmaceutical's Motion #89 to File Under Seal Certain "Confidential" Exhibits Accompanying the Supplemental Declaration of Kate M. Lesciotto in Support of Lupin's Motion for Summary Judgment that the Claims of the U.S. Reissue Patent are Invalid as Obvious #88 . Signed by Magistrate Judge Robert J. Johnston on 7/26/11. (Copies have been distributed pursuant to the NEF - ECS)

Download PDF
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 James E. Whitmire, Esq. (NV Bar No. 6533) SANTORO, DRIGGS, WALCH, KEARNEY, HOLLEY & THOMPSON 400 S. Fourth Street, Third Floor Las Vegas, NV 89101 Telephone: 702-791-0308 Facsimile: 702-791-1912 jwhitmire@nevadafirm.com Of Counsel: Robert F. Green Christopher T. Griffith Salim A. Hasan Kate M. Lesciotto LEYDIG, VOIT & MAYER, LTD. Two Prudential Plaza, Suite 4900 180 N. Stetson Avenue Chicago, IL 60601-6731 Telephone: 312-616-5600 Facsimile: 312-616-5700 rgreen@leydig.com cgriffith@leydig.com shasan@leydig.com klesciotto@leydig.com Attorneys for Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. 17 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEVADA 18 19 20 BAYER SCHERING PHARMA AG & BAYER HEALTHCARE PHARMACEUTICALS INC., 21 Plaintiffs, 22 23 24 v. LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC., 25 Defendants. Civil Case No. 2:10-cv-1166-KJD-RJJ DEFENDANTS LUPIN LIMITED’S AND LUPIN PHARMACEUTICALS, INC.’S MOTION TO FILE UNDER SEAL CERTAIN “CONFIDENTIAL” EXHIBITS ACCOMPANYING THE SUPPLEMENTAL DECLARATION OF KATE M. LESCIOTTO IN SUPPORT OF LUPIN’S MOTION FOR SUMMARY JUDGMENT THAT THE CLAIMS OF THE U.S. REISSUE PATENT ARE INVALID AS OBVIOUS (DKT. 88-2) 26 27 28 -108837-01/Motion to Seal - Lupin's Reply.doc 1 Pursuant to the Protective Order in the above-captioned case (Dkt. 17), Defendants Lupin 2 Limited and Lupin Pharmaceuticals, Inc. (collectively, “Lupin”) seek leave to file under seal 3 certain confidential exhibits accompanying the Supplemental Declaration of Kate M. Lesciotto in 4 Support of Lupin’s Motion for Summary Judgment That The Claims Of The U.S. Reissue Patent 5 Are Invalid As Obvious (Dkt. 88-2) (“Supplemental Lesciotto Declaration”). In support of this 6 Motion, Lupin states as follows: 7 1. The Protective Order in this case permits each party to designate certain 8 information produced during discovery as "CONFIDENTIAL" if the designating party 9 reasonably believes that the information should be protected from public disclosure. (Dkt. 17 at 10 2-3.) The Protective Order further specifies that the parties may file documents under seal under 11 an order of this Court for cause shown. (Id. at 13). 12 2. Certain exhibits attached to the Supplemental Lesciotto Declaration consist of 13 documents or contain citations to documents, that the parties have designated as 14 “CONFIDENTIAL” in this case. 15 16 17 3. Lupin therefore seeks leave of the Court to file certain exhibits accompanying the Supplemental Lesciotto Declaration under seal. 4. In addition, Lupin has concurrently filed a public version of the exhibits to the 18 Supplemental Lesciotto Declaration which redacts only those exhibits that need to remain 19 confidential under the protective order. Specifically, Lupin seeks leave to file under seal Reply 20 Exhibits 2 and 4. 21 22 23 24 25 26 27 28 -208837-01/Motion to Seal - Lupin's Reply.doc 1 Dated this 25th day of July, 2011. SANTORO, DRIGGS, WALCH, KEARNEY, HOLLEY & THOMPSON 2 3 /s/ James E. Whitmire James E. Whitmire (NV Bar No. 6533) SANTORO, DRIGGS, WALCH, KEARNEY, HOLLEY & THOMPSON 400 S. Fourth Street, Third Floor Las Vegas, NV 89101 Telephone: 702-791-0308 Facsimile: 702-791-1912 jwhitmire@nevadafirm.com 4 5 6 7 8 9 Of Counsel: Robert F. Green Christopher T. Griffith Salim A. Hasan Kate M. Lesciotto Leydig, Voit & Mayer, Ltd. Two Prudential Plaza, Suite 4900 180 N. Stetson Avenue Chicago, IL 60601-6731 Telephone: 312-616-5600 Facsimile: 312-616-5700 rgreen@leydig.com cgriffith@leydig.com shasan@leydig.com klesciotto@leydig.com 10 11 12 13 14 15 16 17 18 Attorneys for Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. 19 20 21 22 IT IS SO ORDERED. _____________________________ UNITED STATES MAGISTRATE JUDGE DATE: JULY 26, 2011 23 24 25 26 27 28 -308837-01/Motion to Seal - Lupin's Reply.doc

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?